Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03683589Completed

De Novo Lipogenesis in Severity of NAFLD

Role: collaborator

NCT05591612Not ApplicableCompleted

Increasing Vegetable Intake Using Monosodium Glutamate: A Reduced-Effort Intervention

Role: collaborator

NCT05350579Not ApplicableTerminated

Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults

Role: collaborator

NCT03432585Completed

Parent/Caregiver Conference Attendance Feasibility

Role: collaborator

NCT02558920Unknown

Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity

Role: collaborator

All 5 trials loaded